These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 26463637)
1. Benzophenone derivatives as cysteine protease inhibitors and biological activity against Leishmania(L.) amazonensis amastigotes. de Almeida L; Alves KF; Maciel-Rezende CM; Jesus Lde O; Pires FR; Junior CV; Izidoro MA; Júdice WA; dos Santos MH; Marques MJ Biomed Pharmacother; 2015 Oct; 75():93-9. PubMed ID: 26463637 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation against Leishmania amazonensis of a series of alkyl-substituted benzophenones. Maciel-Rezende CM; de Almeida L; Costa ÉD; Pires FR; Alves KF; Viegas C; Dias DF; Doriguetto AC; Marques MJ; dos Santos MH Bioorg Med Chem; 2013 Jun; 21(11):3114-9. PubMed ID: 23623672 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor. Assis DM; Gontijo VS; de Oliveira Pereira I; Santos JA; Camps I; Nagem TJ; Ellena J; Izidoro MA; dos Santos Tersariol IL; de Barros NM; Doriguetto AC; dos Santos MH; Juliano MA J Enzyme Inhib Med Chem; 2013 Aug; 28(4):661-70. PubMed ID: 22468751 [TBL] [Abstract][Full Text] [Related]
4. Stachytarpheta cayennensis extract inhibits promastigote and amastigote growth in Leishmania amazonensis via parasite arginase inhibition. Maquiaveli CDC; Oliveira E Sá AM; Vieira PC; da Silva ER J Ethnopharmacol; 2016 Nov; 192():108-113. PubMed ID: 27432217 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor. Ribeiro JFR; Cianni L; Li C; Warwick TG; de Vita D; Rosini F; Dos Reis Rocho F; Martins FCP; Kenny PW; Lameira J; Leitão A; Emsley J; Montanari CA Bioorg Med Chem; 2020 Nov; 28(22):115743. PubMed ID: 33038787 [TBL] [Abstract][Full Text] [Related]
7. Leishmanicidal, antiproteolytic, and mutagenic evaluation of alkyltriazoles and alkylphosphocholines. Gontijo VS; Espuri PF; Alves RB; de Camargos LF; Santos FV; de Souza Judice WA; Marques MJ; Freitas RP Eur J Med Chem; 2015 Aug; 101():24-33. PubMed ID: 26112378 [TBL] [Abstract][Full Text] [Related]
14. Novel steroid derivatives: synthesis, antileishmanial activity, mechanism of action, and in silico physicochemical and pharmacokinetics studies. da Trindade Granato J; Dos Santos JA; Calixto SL; Prado da Silva N; da Silva Martins J; da Silva AD; Coimbra ES Biomed Pharmacother; 2018 Oct; 106():1082-1090. PubMed ID: 30119174 [TBL] [Abstract][Full Text] [Related]
15. Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect. Prada CF; Alvarez-Velilla R; Balaña-Fouce R; Prieto C; Calvo-Álvarez E; Escudero-Martínez JM; Requena JM; Ordóñez C; Desideri A; Pérez-Pertejo Y; Reguera RM Biochem Pharmacol; 2013 May; 85(10):1433-40. PubMed ID: 23466420 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates. Romeiro NC; Aguirre G; Hernández P; González M; Cerecetto H; Aldana I; Pérez-Silanes S; Monge A; Barreiro EJ; Lima LM Bioorg Med Chem; 2009 Jan; 17(2):641-52. PubMed ID: 19110434 [TBL] [Abstract][Full Text] [Related]
17. Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi. Trossini GH; Malvezzi A; T-do Amaral A; Rangel-Yagui CO; Izidoro MA; Cezari MH; Juliano L; Chin CM; Menezes CM; Ferreira EI J Enzyme Inhib Med Chem; 2010 Feb; 25(1):62-7. PubMed ID: 20030510 [TBL] [Abstract][Full Text] [Related]
18. Metal compounds for the treatment of parasitic diseases. Fricker SP; Mosi RM; Cameron BR; Baird I; Zhu Y; Anastassov V; Cox J; Doyle PS; Hansell E; Lau G; Langille J; Olsen M; Qin L; Skerlj R; Wong RS; Santucci Z; McKerrow JH J Inorg Biochem; 2008 Oct; 102(10):1839-45. PubMed ID: 18684510 [TBL] [Abstract][Full Text] [Related]
19. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors. Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1. Fonseca NC; da Cruz LF; da Silva Villela F; do Nascimento Pereira GA; de Siqueira-Neto JL; Kellar D; Suzuki BM; Ray D; de Souza TB; Alves RJ; Sales Júnior PA; Romanha AJ; Murta SM; McKerrow JH; Caffrey CR; de Oliveira RB; Ferreira RS Antimicrob Agents Chemother; 2015 May; 59(5):2666-77. PubMed ID: 25712353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]